| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P819 | ADS bibcode | 2015NatSR...513677Y |
| P6179 | Dimensions Publication ID | 1007774635 |
| P356 | DOI | 10.1038/SREP13677 |
| P932 | PMC publication ID | 4556976 |
| P698 | PubMed publication ID | 26330060 |
| P5875 | ResearchGate publication ID | 281518119 |
| P2093 | author name string | Jie Yang | |
| Dazhi Xu | |||
| Lihua Yang | |||
| Shaomin Wang | |||
| Zhaohui Gong | |||
| Shun Zhang | |||
| Yanping Le | |||
| Jingqiu Li | |||
| Chengwei Zhou | |||
| Xingkai Shen | |||
| P2860 | cites work | MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1 | Q21245764 |
| Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer | Q39236863 | ||
| The proto-oncogene Pim-1 is a target of miR-33a | Q39509450 | ||
| MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma | Q39521098 | ||
| Lin-28 reactivation is required for let-7 repression and proliferation in human small cell lung cancer cells | Q39546229 | ||
| miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma. | Q45907906 | ||
| Regulation of the twist target gene tinman by modular cis-regulatory elements during early mesoderm development | Q47070871 | ||
| MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cells. | Q51821489 | ||
| miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1. | Q53248542 | ||
| MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines. | Q54244950 | ||
| MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling | Q85648231 | ||
| Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence | Q24309539 | ||
| MicroRNA-338-3p and microRNA-451 contribute to the formation of basolateral polarity in epithelial cells | Q24642812 | ||
| A twist for survival and cancer progression | Q24652500 | ||
| The basics of epithelial-mesenchymal transition | Q24652992 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis | Q28131703 | ||
| Tumour invasion and metastasis initiated by microRNA-10b in breast cancer | Q28131829 | ||
| A perspective on cancer cell metastasis | Q28307891 | ||
| MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis | Q28509140 | ||
| Lung cancer | Q29615473 | ||
| The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs | Q29615910 | ||
| A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition | Q29617690 | ||
| miR-33 links SREBP-2 induction to repression of sterol transporters | Q33981907 | ||
| Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes | Q34100400 | ||
| miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions | Q34237504 | ||
| RAC1 activation mediates Twist1-induced cancer cell migration | Q34260423 | ||
| miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer | Q34288764 | ||
| Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer | Q34422999 | ||
| EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells | Q34803710 | ||
| A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. | Q35503722 | ||
| Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence. | Q35678607 | ||
| Epithelial-mesenchymal transitions: twist in development and metastasis | Q35856121 | ||
| Mir-33 regulates cell proliferation and cell cycle progression. | Q35881967 | ||
| MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network | Q36466643 | ||
| MicroRNA-33a mediates the regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid transcription factor 1 (TTF-1/NKX2-1) | Q36910037 | ||
| Metastamir: the field of metastasis-regulatory microRNA is spreading | Q37373263 | ||
| TWISTing an embryonic transcription factor into an oncoprotein | Q37728859 | ||
| EMT as the ultimate survival mechanism of cancer cells | Q37992416 | ||
| Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs | Q38083976 | ||
| Clusterin mediates TGF-β-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cells | Q38322593 | ||
| Twist1 induces endothelial differentiation of tumour cells through the Jagged1-KLF4 axis. | Q38963889 | ||
| miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis | Q39043666 | ||
| MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9. | Q39085254 | ||
| MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein | Q39185667 | ||
| P5824 | is retracted by | Retraction Note: MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer | Q114674313 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| P304 | page(s) | 13677 | |
| P577 | publication date | 2015-09-02 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | RETRACTED ARTICLE: MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer | |
| P478 | volume | 5 |
| Q48260919 | A Novel TP53 Mutation Associated with TWIST1 and SIP1 Expression in an Aggressive Adrenocortical Carcinoma. |
| Q59335321 | A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer |
| Q28069990 | Advanced Research on MicroRNAs and EGFR-TKIs Secondary Resistance |
| Q90917759 | Antiproliferative potential of miR-33a in laryngeal cancer Hep-2 cells via targeting PIM1 |
| Q36264911 | Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy |
| Q96686252 | Bioinformatics Analysis of Prognostic miRNA Signature and Potential Critical Genes in Colon Cancer |
| Q38727483 | Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2. |
| Q38813476 | Bonafide Targets of Deregulated microRNAs in Non-Small Cell Lung Cancer as Tool to Identify Novel Therapeutic Targets: A Review |
| Q92544355 | CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging |
| Q112642011 | Clinical Value and Potential Mechanism of miRNA-33a-5p in Lung Squamous Cell Carcinoma |
| Q55243832 | Differential microRNA expression profiles between young and old lung adenocarcinoma patients. |
| Q33650801 | Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling |
| Q26749113 | Epigenetics in non-small cell lung cancer: from basics to therapeutics |
| Q41552614 | Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer |
| Q89537408 | Long Non-Coding RNA EGOT Promotes the Malignant Phenotypes of Hepatocellular Carcinoma Cells and Increases the Expression of HMGA2 via Down-Regulating miR-33a-5p |
| Q38734500 | Long and short noncoding RNAs in lung cancer precision medicine: Opportunities and challenges |
| Q90608122 | MiR-33a functions as a tumor suppressor in triple-negative breast cancer by targeting EZH2 |
| Q38730636 | MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA. |
| Q38728566 | MiR-509-5p suppresses the proliferation, migration, and invasion of non-small cell lung cancer by targeting YWHAG. |
| Q38736937 | MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer |
| Q38910342 | MicroRNA Exert Macro Effects on Cancer Bone Metastasis |
| Q26771110 | MicroRNA Regulation of Epithelial to Mesenchymal Transition |
| Q64108079 | MicroRNA in Lung Cancer Metastasis |
| Q38757136 | MicroRNA-27a-3p regulates epithelial to mesenchymal transition via targeting YAP1 in oral squamous cell carcinoma cells |
| Q38696247 | MicroRNA-33a and let-7e inhibit human colorectal cancer progression by targeting ST8SIA1. |
| Q37520584 | MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma |
| Q38800334 | MicroRNA-455 suppresses non-small cell lung cancer through targeting ZEB1. |
| Q39028929 | MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases |
| Q49622015 | NKX2-1 expression as a prognostic marker in early-stage non-small-cell lung cancer |
| Q33829653 | Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer |
| Q41126547 | PFKL/miR-128 axis regulates glycolysis by inhibiting AKT phosphorylation and predicts poor survival in lung cancer |
| Q47976928 | Pecanex functions as a competitive endogenous RNA of S-phase kinase associated protein 2 in lung cancer |
| Q61806377 | RASSF1C regulates miR-33a and EMT marker gene expression in lung cancer cells |
| Q92104040 | Rab6 regulates cell migration and invasion by recruiting Cdc42 and modulating its activity |
| Q39458257 | Recent progress on the effects of microRNAs and natural products on tumor epithelial-mesenchymal transition. |
| Q98386379 | Role of microRNA-33a in malignant cells |
| Q46340515 | Suppression of SIRT6 by miR-33a facilitates tumor growth of glioma through apoptosis and oxidative stress resistance |
| Q99712026 | Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy |
| Q58729731 | The Dual Role of MicroRNAs in Colorectal Cancer Progression |
| Q64098894 | The Roles of MicroRNA in Lung Cancer |
| Q91812552 | The effects of tracheal occlusion on Wnt signaling in a rabbit model of congenital diaphragmatic hernia |
| Q38646345 | The role of TWIST1 in epithelial-mesenchymal transition and cancers |
| Q38775913 | The role of microRNA in metastatic processes of non-small cell lung carcinoma. |
| Q37618382 | Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression |
| Q92839324 | Vasculogenic mimicry and expression of Twist1 and KAI1 correlate with metastasis and prognosis in lung squamous cell carcinoma |
| Q91546171 | ZNF281/Zfp281 is a target of miR-1 and counteracts muscle differentiation |
| Q92666274 | lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling |
| Q28588589 | miR-151-3p Targets TWIST1 to Repress Migration of Human Breast Cancer Cells |
| Q53665464 | miR-33a expression sensitizes Lgr5+ HCC-CSCs to doxorubicin via ABCA1. |
| Q41694147 | miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer. |
| Q52683995 | miR-33a-5p enhances the sensitivity of lung adenocarcinoma cells to celastrol by regulating mTOR signaling. |
| Q50064930 | miRNA in tumour metabolism and why could it be the preferred pathway for energy reprograming |